Navigation Links
NHP Reports 2008 Fourth Quarter and Full Year Results
Date:2/18/2009

- 2008 Investments of $591 Million Yield Growth in Revenue, Recurring Diluted FFO and FAD Per Share

- Balance Sheet Remains Strong With Modest Capital Commitments Through Mid-2011

NEWPORT BEACH, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Nationwide Health Properties, Inc. (NYSE: NHP) today announced results of operations for the fourth quarter and the year ended December 31, 2008. Contemporaneously with this press release, the Company has filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2008 with the Securities and Exchange Commission.

"In 2008, we continued our track record of growth, diversification and balance sheet strength, delivering a strong performance against commonly-used metrics," commented Douglas M. Pasquale, NHP's President and Chief Executive Officer. "Our disciplined approach to acquisitions and balance sheet management has resulted in conservative leverage, an excellent fixed charge coverage and ample liquidity. Given the strength of our balance sheet and modest capital commitments, we believe we have positioned ourselves well to capitalize on strategic opportunities as they arise. Our total shareholder return, diluted FAD dividend payout ratio and coverage remain among the strongest in the entire REIT universe," Mr. Pasquale added.

FOURTH QUARTER 2008 RESULTS OF OPERATIONS

The following table presents selected financial information for the fourth quarter and the year ended December 31, 2008 as compared to the same periods of 2007:



                         SELECTED FINANCIAL DATA
                ($in thousands, except per share amounts)

                                         Three Months Ended
                                            December 31,
                                 -----------------------------------
                                 2008     2007   $ Change   % Change
                                 -----------------------------------

    Revenue                     $96,470  $83,616  $12,854      15.4%
    Income from Continuing
     Operations                 $31,462  $38,509  $(7,047)    -18.3%
    Net Income                  $33,416  $53,236 $(19,820)    -37.2%
    Income Available to Common
     Stockholders Per Diluted
     Share                        $0.31    $0.54   $(0.23)    -42.6%
    Diluted FFO                 $64,002  $54,989   $9,013      16.4%
    Recurring Diluted FFO       $59,361  $53,322   $6,039      11.3%
    Diluted FFO Per Share         $0.60    $0.56    $0.04       7.1%
    Recurring Diluted FFO Per
     Share                        $0.56    $0.54    $0.02       3.7%
    Diluted FAD                 $58,554  $53,914   $4,640       8.6%
    Recurring Diluted FAD       $58,554  $52,247   $6,307      12.1%
    Diluted FAD Per Share         $0.55    $0.55       $-       0.0%
    Recurring Diluted FAD Per
     Share                        $0.55    $0.53    $0.02       3.8%

                                            Year Ended
                                            December 31,
                                 -----------------------------------
                                 2008     2007  $ Change    % Change
                                 -----------------------------------

    Revenue                    $370,665 $306,269  $64,396      21.0%
    Income from Continuing
     Operations                $108,140 $132,633 $(24,493)    -18.5%
    Net Income                 $268,138 $224,458  $43,680      19.5%
    Income Available to Common
     Stockholders Per Diluted
     Share                        $2.64    $2.32    $0.32      13.8%
    Diluted FFO                $236,514 $203,203  $33,311      16.4%
    Recurring Diluted FFO      $231,873 $199,571  $32,302      16.2%
    Diluted FFO Per Share         $2.29    $2.12    $0.17       8.0%
    Recurring Diluted FFO Per
     Share                        $2.24    $2.08    $0.16       7.7%
    Diluted FAD                $226,327 $205,019  $21,308      10.4%
    Recurring Diluted FAD      $226,327 $201,387  $24,940      12.4%
    Diluted FAD Per Share         $2.19    $2.14    $0.05       2.3%
    Recurring Diluted FAD Per
     Share                        $2.19    $2.10    $0.09       4.3%



NON-GAAP FINANCIAL MEASURES

Diluted Funds From Operations ("FFO") and Diluted Funds Available for Distribution ("FAD") are non-GAAP measures that we believe are important to understanding our operations. We believe diluted FFO is an important supplemental measure of operating performance because it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). We believe diluted FAD is an important supplemental measure of operating performance because, like diluted FFO, it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). It also excludes straight-lined rent and other non-cash items that have become more significant for us and our competitors over the last several years. We believe that net income is the most directly comparable GAAP measure to diluted FFO and diluted FAD. Reconciliations between net income and diluted FFO and net income and diluted FAD are included in the accompanying financial data. For guidance, we have also included in the accompanying financial data reconciliations between net income per share and diluted FFO and diluted FAD per share. We have also included recurring diluted FFO and recurring diluted FAD amounts which exclude the recognition of revenue related to cash received from a tenant related to previously reserved rental revenue, interest income and late charges in 2007 and excludes the recognition of a gain on debt extinguishment in 2008.

INCOME FROM CONTINUING OPERATIONS

In 2007, we sold properties to our unconsolidated joint venture with a state pension fund investor. Under generally accepted accounting principles ("GAAP"), we were required to recognize a gain on this sale and because we have a continuing involvement in these properties through an unconsolidated joint venture, we were required to include this gain on sale in income from continuing operations. As a result, our income from continuing operations for the three months and year ending December 31, 2007, is substantially greater than the three months and year ending December 31, 2008.

FOURTH QUARTER 2008 INVESTMENT ACTIVITY

The following table summarizes our 2008 investment activity:




                            INVESTMENT ACTIVITY 2008
                                ($in thousands)

                           Q1       Q2        Q3         Q4     Year to Date
    Investment           Total     Total     Total   Owned (1)      Total
    ------------------------------------------------------------------------
    Senior Housing
      Number of
       Facilities           14         1         -          3            18
      Purchase Price
       (2)             $52,000   $20,000        $-    $26,000       $98,000
      Initial Yield        8.1%      8.3%                 8.4%          8.2%
    ------------------------------------------------------------------------
    Long-Term Care
      Number of
       Facilities            -         7         5          1            13
      Purchase Price
       (2)                  $-   $32,000   $32,000    $22,000       $86,000
      Initial Yield                  9.4%      9.7%       9.7%          9.6%
    ------------------------------------------------------------------------
    Medical Office
      Number of
       Facilities            1         8        15          2            26
      Purchase Price
       (3)              $2,000  $198,000  $110,000    $49,000      $359,000
      Initial Yield        7.4%      6.0%      7.2%       6.0%          6.3%
    ------------------------------------------------------------------------
    Investments in
     Existing
     Portfolio
      Investment        $6,000    $9,000   $13,000    $20,000       $48,000
      Initial Yield        8.7%      8.0%      8.3%       7.8%          8.1%
    ------------------------------------------------------------------------
    Total
      Number of
       Facilities           15        16        20          6            57
      Purchase Price   $60,000  $259,000  $155,000   $117,000      $591,000
      Initial Yield        8.1%      6.6%      7.8%       7.5%          7.3%
    ------------------------------------------------------------------------

    (1)  There were no loans placed in the fourth quarter.
    (2)  The Q4 total includes the exercise for $8.0 million (Senior Housing)
         and $13.0 million (Long-Term Care) of purchase options by one of our
         JVs in which we hold a 25% interest.
    (3)  The Q3 total has been adjusted to reflect $19.0 million invested in
         two MOBs by a JV in which we hold a 44.95% interest.


Pacific Medical Buildings LLC ("PMB") Update - During 2008, we directly or indirectly acquired or otherwise invested in 12 PMB medical office buildings previously owned by affiliates of PMB. The gross investment was $266.2 million, including the assumption of $132.4 million of mortgage financing and the issuance of 1,829,562 limited operating partnership units with a value of $58.4 million. Additionally, in September 2008, we made a $47.5 million mortgage loan, which is secured by a medical office building, to a PMB affiliate which has the right to extend the loan until August 2009.

2008 FINANCING TRANSACTIONS

During the fourth quarter of 2008, we issued 2.4 million shares of our common stock through our controlled equity offering program at an average price of $29.29 per share, resulting in net proceeds of approximately $69.0 million. For the year ended December 31, 2008, we issued 5.0 million shares of our common stock through our controlled equity offering program at an average price of $32.24 per share resulting in net proceeds of approximately $158.1 million.

During the fourth quarter of 2008, we converted 314,716 shares of series B cumulative convertible preferred stock into 1.4 million shares of common stock.

During the fourth quarter of 2008, we retired $49.7 million of medium term notes with a weighted average interest rate of 7.15% for $44.6 million, resulting in a $4.6 million gain on extinguishment of debt net of related deferred financing costs.

2009 GUIDANCE

Our diluted FFO guidance per share range is from $2.20 to $2.25 and our diluted FAD guidance per share range is from $2.18 to $2.23. Our guidance excludes any acquisitions, investments, impairments or capital transactions occurring in 2009. Current guidance also assumes no material changes to the Hearthstone lease nor the recognition of any supplemental rent previously or prospectively deferred. Beginning in 2009, certain costs associated with acquisitions which were previously capitalized are now required to be expensed. While our guidance does not assume any acquisitions, we will incur certain costs that will be expensed for any acquisitions we may make and those costs could be material.

CONFERENCE CALL INFORMATION

We have scheduled a conference call and webcast on Thursday, February 19, 2009 at 8:30 a.m. Pacific time (11:30 a.m. Eastern time) in order to present our performance and operating results for the quarter and year ended December 31, 2008. The conference call is accessible by dialing 877-356-5705 and referencing conference ID number 83294465 or by logging on to our website at http://www.nhp-reit.com. The international dial-in number is 973-200-3389. The earnings release and any additional financial information that may be discussed on the conference call will also be available at the same location on our website. A digitized replay of the conference call will be available from 10:30 a.m. Pacific time (1:30 p.m. Eastern time) that day until 9:00 p.m. Pacific time (Midnight Eastern time) on Thursday, March 19, 2009. Callers can access the replay by dialing 800-642-1687 or 706-645-9291 and entering conference ID number 83294465. Webcast replays will also be available on our website for at least 12 months following the conference call. Our supplemental information package for the quarter ended December 31, 2008 is available on our website, free of charge, at http://www.nhp-reit.com by selecting "Investor Relations" followed by "Financial Information" and will be included in our Current Report on Form 8-K filed February 18, 2009 with the SEC also containing this release. Shareholders may receive free of charge a complete set of our audited financial statements upon request.

ABOUT NATIONWIDE HEALTH PROPERTIES, INC.

Nationwide Health Properties, Inc. is a real estate investment trust that invests in senior housing facilities, long-term care facilities and medical office buildings. We have investments in 582 facilities in 43 states. For more information on Nationwide Health Properties, Inc., visit our website at http://www.nhp-reit.com.

FORWARD LOOKING STATEMENTS

Certain information contained in this release includes forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are not statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as "may," "will," "anticipates," "expects," "believes," "intends," "should" or comparable terms or the negative thereof. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. Risks and uncertainties associated with our business include (without limitation) the following: deterioration in the operating results or financial condition, including bankruptcies, of our tenants; non-payment or late payment of rent by our tenants; our reliance on two tenants for a significant percentage of our revenue; occupancy levels at certain facilities; our level of indebtedness; changes in the ratings of our debt securities; access to the capital markets and the cost of capital; government regulations, including changes in the reimbursement levels under the Medicare and Medicaid programs; the general distress of the healthcare industry; increasing competition in our business sector; the effect of economic and market conditions and changes in interest rates; the amount and yield of any additional investments; risks associated with acquisitions, including our ability to identify and complete favorable transactions, delays or failures in obtaining third party consents or approvals, the failure to achieve perceived benefits, unexpected costs or liabilities and potential litigation; the ability of our tenants to repay straight-line rent or loans in future periods; the ability of our tenants to obtain and maintain adequate liability and other insurance; our ability to attract new tenants for certain facilities; our ability to sell certain facilities for their book value; our ability to retain key personnel; potential liability under environmental laws; the possibility that we could be required to repurchase some of our senior notes; the rights and influence of holders of our outstanding preferred stock; changes in or inadvertent violations of tax laws and regulations and other factors that can affect real estate investment trusts and our status as a real estate investment trust; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission, especially the "Risk Factors" sections of our Annual and Quarterly Reports on Forms 10-K and 10-Q. Forward-looking information is provided by us pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. We disclaim any intent or obligation to update these forward-looking statements.

    Contact:
    Abdo H. Khoury
    Chief Financial and Portfolio Officer
    (949) 718-4400

***Financial Tables to Follow***



                     NATIONWIDE HEALTH PROPERTIES, INC.
                   CONSOLIDATED STATEMENTS OF OPERATIONS
                   (In thousands, except per share data)

                                 Three Months Ended    Year Ended
                                     December 31,      December 31,
                                    -------------     --------------
                                    2008     2007     2008      2007
                                    -------------     --------------
    Revenue:
      Triple net lease rent       $72,691  $70,651  $285,398  $268,346
      Medical office building
       operating rent              17,229    6,928    60,287    16,061
                                   ------    -----    ------    ------
                                   89,920   77,579   345,685   284,407
      Interest and other income     6,550    6,037    24,980    21,862
                                    -----    -----    ------    ------
                                   96,470   83,616   370,665   306,269
    Expenses:
      Interest and
       amortization of
       deferred financing
       costs                       25,492   25,435   101,045    97,639
      Depreciation and
       amortization                30,898   26,110   117,473    91,187
      General and
       administrative               6,513    6,937    26,051    24,429
      Medical office building
       operating expenses           7,849    3,512    26,631     8,596
                                    -----    -----    ------     -----
                                   70,752   61,994   271,200   221,851
                                   ------   ------   -------   -------
    Income before
     minority interests,
     unconsolidated
     joint ventures and
     discontinued operations       25,718   21,622    99,465    84,418
      Minority interests               24       73       131       212
      Income from
       unconsolidated joint
       ventures                     1,079      717     3,903     1,958
      Gain on
       extinguishment of
       debt, net                    4,641        -     4,641         -
      Gain on sale of facilities
       to unconsolidated joint
       venture                          -   16,097         -    46,045
                                   ------   ------     -----    ------
    Income from
     continuing
     operations                    31,462   38,509   108,140   132,633

    Discontinued
     operations
      Gain on sale of
       facilities, net              1,552   10,783   154,995    72,069
      Income from
       discontinued
       operations                     402    3,944     5,003    19,756
                                      ---    -----     -----    ------
                                    1,954   14,727   159,998    91,825
                                    -----   ------   -------    ------

    Net income                     33,416   53,236   268,138   224,458
      Preferred stock dividends    (1,452)  (2,062)   (7,637)  (13,434)
                                   ------   ------    ------   -------
    Income available
     to common
     stockholders                 $31,964  $51,174  $260,501  $211,024
                                  =======  =======  ========  ========

    Basic earnings per
     share (EPS):
      Income from
       continuing
       operations
       excluding gains              $0.25    $0.22     $0.98     $0.81
      Gains in income from
       continuing operations         0.05     0.17      0.05      0.51
                                     ----     ----      ----      ----
      Income from
       continuing
       operations                    0.30     0.39      1.03      1.32
      Discontinued operations        0.02     0.16      1.65      1.01
                                     ----     ----      ----      ----
      Income available to
       common stockholders          $0.32    $0.55     $2.68     $2.33
                                    =====    =====     =====     =====

    Diluted EPS:
      Income from
       continuing
       operations
       excluding gains              $0.25    $0.22     $0.97     $0.80
      Gain in income from
       continuing operations         0.04     0.17      0.05      0.51
                                     ----     ----      ----      ----
      Income from
       continuing
       operations                    0.29     0.39      1.02      1.31
      Discontinued operations        0.02     0.15      1.62      1.01
                                     ----     ----      ----      ----
      Income available to
       common stockholders          $0.31    $0.54     $2.64     $2.32
                                    =====    =====     =====     =====

    Weighted average
     shares outstanding
     for EPS:
      Basic                       100,353   93,399    97,246    90,625
                                  =======   ======    ======    ======
      Diluted                     102,455   93,990    98,855    91,129
                                  =======   ======    ======    ======



                NATIONWIDE HEALTH PROPERTIES, INC.
       RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
               (In thousands, except per share data)

     Reconciliation of Net Income to Diluted FFO and Recurring
                            Diluted FFO

                        Three Months Ended    Year Ended
                           December 31,       December 31,
                           -------------     --------------
                           2008     2007     2008      2007
                           ----     ----     ----      ----

    Net income           $33,416  $53,236  $268,138  $224,458
      Preferred stock
       dividends          (1,452)  (2,062)   (7,637)  (13,434)
      Real estate
       related
       depreciation and
       amortization       30,837   27,965   118,603   100,340
      Depreciation in
       income from
       unconsolidated
       joint ventures      1,301      668     4,768     1,703
      Gains on sale of
       facilities, net    (1,552) (26,880) (154,995) (118,114)
                          ------  -------  --------  --------
    FFO available to
     common stockholders  62,550   52,927   228,877   194,953
      Series B
       preferred
       dividends           1,452    2,062     7,637     8,250
                           -----    -----     -----     -----
    Diluted FFO           64,002   54,989   236,514   203,203
      Gain on
       extinguishment of
       debt, net          (4,641)       -    (4,641)        -
      Non-recurring
       settlement of
       tenant
       obligations             -   (1,667)        -    (3,632)
                         -------   ------   -------    ------
    Recurring diluted
     FFO                 $59,361  $53,322  $231,873  $199,571
                         =======  =======  ========  ========

    Weighted average
     shares outstanding
     for diluted FFO:
      Diluted weighted
       average shares
       outstanding       102,455   93,990    98,855    91,129
      Series B
       preferred stock
       conversion          3,896    4,717     4,526     4,707
                           -----    -----     -----     -----
      Fully diluted
       weighted average
       shares
       outstanding       106,351   98,707   103,381    95,836
                         =======   ======   =======    ======

    Diluted FFO per
     share                 $0.60    $0.56     $2.29     $2.12
                           =====    =====     =====     =====
    Recurring diluted
     FFO per share         $0.56    $0.54     $2.24     $2.08
                           =====    =====     =====     =====

    Dividends declared
     per common share      $0.44    $0.41     $1.76     $1.64
                           =====    =====     =====     =====

    Recurring diluted
     FFO payout ratio         79%      76%       79%       79%
                              ==       ==        ==        ==
    Recurring diluted
     FFO coverage           1.27     1.32      1.27      1.27
                            ====     ====      ====      ====



                        NATIONWIDE HEALTH PROPERTIES, INC.
           RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
                       (In thousands, except per share data)

       Reconciliation of Net Income to Diluted FAD and Recurring Diluted FAD

                                       Three Months Ended     Year Ended
                                           December 31,       December 31,
                                           -------------     --------------
                                           2008     2007     2008      2007
                                           ----     ----     ----      ----

    Net income                           $33,416  $53,236  $268,138  $224,458
      Preferred stock dividends           (1,452)  (2,062)   (7,637)  (13,434)
      Real estate related depreciation
       and amortization                   30,837   27,965   118,603   100,340
      Gains on sale of facilities, net    (1,552) (26,880) (154,995) (118,114)
      Gain on extinguishment of debt,
       net                                (4,641)       -    (4,641)        -
      Straight-lined rent                 (2,388)  (1,735)  (10,263)   (2,886)
      Amortization of intangible assets
       and liabilities                      (148)     (74)     (559)      (96)
      Non-cash stock-based compensation
       expense                             1,528    1,247     5,800     4,733
      Deferred finance cost amortization     908      737     3,173     2,803
      Lease commissions and tenant and
       capital improvements                 (716)  (1,260)   (3,715)   (2,758)
      Unconsolidated joint ventures:
        Real estate related
         depreciation and amortization     1,301      668     4,768     1,703
        Straight-lined rent                  (12)       -       (66)        -
        Deferred finance cost
         amortization                         21       10        84        20
                                              --       --        --        --
    FAD available to common
     stockholders                         57,102   51,852   218,690   196,769
      Series B preferred dividends         1,452    2,062     7,637     8,250
                                           -----    -----     -----     -----
    Diluted FAD                           58,554   53,914   226,327   205,019
        Non-recurring settlement of
         delinquent tenant obligations         -   (1,667)        -    (3,632)
                                               -   ------         -    ------
    Recurring diluted FAD                $58,554  $52,247  $226,327  $201,387
                                         =======  =======  ========  ========

    Weighted average shares
     outstanding for diluted FAD:
      Weighted average shares
       outstanding                       102,455   93,990    98,855    91,129
      Series B preferred stock
       conversion                          3,896    4,717     4,526     4,707
                                           -----    -----     -----     -----
      Fully diluted weighted average
       shares outstanding                106,351   98,707   103,381    95,836
                                         =======   ======   =======    ======

    Diluted FAD per share                  $0.55    $0.55     $2.19     $2.14
                                           =====    =====     =====     =====
    Recurring FAD diluted  per share       $0.55    $0.53     $2.19     $2.10
                                           =====    =====     =====     =====

    Dividends declared per common
     share                                 $0.44    $0.41     $1.76     $1.64
                                           =====    =====     =====     =====

    Recurring diluted FAD payout
     ratio                                    80%      77%       80%       78%
                                              ==       ==        ==        ==
    Recurring diluted FAD coverage          1.25     1.29      1.24      1.28
                                            ====     ====      ====      ====



        Reconciliation of 2009 Net Income Guidance to 2009 Diluted FFO and
                   Diluted FAD Guidance on a Per Share Basis

                                Low         High
                                ---         ----
    Net income                 $1.07        $1.12
      Real estate related
       depreciation and
       amortization             1.14         1.14
      Dilution from
       convertible preferred
       stock                   (0.01)       (0.01)
                               -----        -----
    Diluted FFO guidance        2.20         2.25
                                ----         ----
      Straight-lined rent      (0.06)       (0.06)
      Amortization of
       intangible assets and
       liabilities             (0.01)       (0.01)
      Non-cash stock- based
       compensation expense     0.07         0.07
      Deferred finance cost
       amortization             0.03         0.03
      Lease commissions and
       tenant and capital
       improvements            (0.05)       (0.05)
                               -----        -----
    Diluted FAD
     guidance                  $2.18        $2.23
                               =====        =====



                       NATIONWIDE HEALTH PROPERTIES, INC.
                           CONSOLIDATED BALANCE SHEETS
                                 (In thousands)

                                                 December 31,   December 31,
                                                      2008          2007
                                                      ----          ----
    Assets
      Real estate related investments:
        Land                                         $320,394      $301,100
        Buildings and improvements                  3,079,819     2,896,876
                                                    ---------     ---------
                                                    3,400,213     3,197,976
        Less accumulated depreciation                (490,112)     (410,865)
                                                     --------      --------
          Net real estate                           2,910,101     2,787,111
        Mortgage loans receivable, net                112,399       121,694
        Mortgage loan receivable from related
         party                                         47,500             -
        Investment in unconsolidated joint
         ventures                                      54,299        52,637
                                                       ------        ------
          Net real estate related investments       3,124,299     2,961,442
      Cash and cash equivalents                        82,250        19,407
      Receivables, net                                  6,066         3,808
      Assets held for sale                              4,542             -
      Intangible assets                               109,434        58,481
      Other assets                                    131,534       101,215
                                                      -------       -------
          Total assets                             $3,458,125    $3,144,353
                                                   ==========    ==========

    Liabilities and Stockholders' Equity
      Unsecured senior credit facility                     $-       $41,000
      Senior notes due 2009 - 2038                  1,056,233     1,166,500
      Notes and bonds payable                         435,199       340,150
      Accounts payable and accrued
       liabilities                                    144,566       107,844
                                                      -------       -------
        Total liabilities                           1,635,998     1,655,494

      Minority interests                               61,460         6,166

      Stockholders' equity:
        Series B convertible preferred stock           74,918       106,445
        Common stock                                   10,228         9,481
        Capital in excess of par value              1,786,193     1,565,249
        Cumulative net income                       1,556,889     1,288,751
        Accumulated other comprehensive income          1,846         2,561
        Cumulative dividends                       (1,669,407)   (1,489,794)
                                                   ----------    ----------
        Total stockholders' equity                  1,760,667     1,482,693
                                                    ---------     ---------
          Total liabilities and stockholders'
           equity                                  $3,458,125    $3,144,353
                                                   ==========    ==========



'/>"/>
SOURCE Nationwide Health Properties, Inc.
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... 2016 , ... Miami Dental Specialists is excited to bring patients the choice ... in January, Miami Dental Specialists will offer the non-metal implants as a safe, holistic ... be chosen by the dental implant manufacturer, Straumann, to bring this cutting-edge technology to ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... “Revolutionizing Cancer Care.” , The print component of “Revolutionizing Cancer Care” ... Pittsburgh/Cleveland, New York, Washington DC/Baltimore, and Seattle, with a circulation of approximately 250,000 ...
(Date:2/12/2016)... ... 12, 2016 , ... Homeowners now have a next generation ... America’s leading brand of building products, has improved upon its industry-best array of ... version of the ColorView® Exterior Style and Color Selector. Created expressly for the ...
(Date:2/12/2016)... ... ... Healthcare careers in the medical laboratory, nursing, and in the imaging field ... staffing leader Aureus Medical Group during the month of January. Aureus Medical specializes in ... and in travel and direct hire opportunities in other allied health fields. , The ...
(Date:2/12/2016)... ... February 12, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... what he says are the real facts surrounding all those Bible stories. For generations ... Sunday school teachers, and Yisrayl says there is more to these than just mere ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Kalifornien, 12. Februar 2016  Sequent Medical, Inc. ... von Patienten für eine Studie zur Sicherheit und ... speziell für die Behandlung von rupturierten intrakraniellen Aneurysmen ... Leiter der Neuroradiologie an der Universitätsklinik Bicètre in ... der CLARYS-Studie hat den ersten Patienten aufgenommen. ...
(Date:2/12/2016)... 2016  Eli Lilly and Company (NYSE: LLY ) ... (pemetrexed disodium) vitamin regimen patent would not presently be infringed ... France , Italy and ... only with dextrose solution.  --> ... of Appeal held that Lilly,s patent would be indirectly infringed ...
(Date:2/12/2016)... February 12, 2016 ... auf den ungedeckten medizinischen Bedarf bei Lungen- ... seines klinischen Forschungsprogramms bekannt. Das Programm, das ... Verbesserungen ihrer respiratorischen Funktionen und anderer klinischer ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ...
Breaking Medicine Technology: